Evidence map›Paper›PMID 34276223›Full record

ArticleJournal of inflammation research2021

Oral Limonite Supplement Ameliorates Glucose Intolerance in Diabetic and Obese Mice.

Akihiro Uchida, Taro Yasuma, Atsuro Takeshita, Masaaki Toda, Yuko Okano, Kota Nishihama, Corina N D'Alessandro-Gabazza, Valeria Fridman D'Alessandro, Chisa Inoue, Takehiro Takagi and 5 more

Open access · goldAbstract read
In one paragraph

Article in Journal of inflammation research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Akihiro Uchida *Department of Diabetes and Endocrinology, Mie University Faculty and Graduate School of Medicine, Tsu, Mie, Japan.
Taro Yasuma *Department of Diabetes and Endocrinology, Mie University Faculty and Graduate School of Medicine, Tsu, Mie, Japan.
Atsuro Takeshita *Department of Diabetes and Endocrinology, Mie University Faculty and Graduate School of Medicine, Tsu, Mie, Japan.
Masaaki TodaDepartment of Immunology, Mie University Faculty and Graduate School of Medicine, Tsu, Mie, Japan.
Yuko OkanoDepartment of Diabetes and Endocrinology, Mie University Faculty and Graduate School of Medicine, Tsu, Mie, Japan.
Kota NishihamaDepartment of Diabetes and Endocrinology, Mie University Faculty and Graduate School of Medicine, Tsu, Mie, Japan.
Corina N D'Alessandro-GabazzaDepartment of Immunology, Mie University Faculty and Graduate School of Medicine, Tsu, Mie, Japan.
Valeria Fridman D'AlessandroDepartment of Immunology, Mie University Faculty and Graduate School of Medicine, Tsu, Mie, Japan.
Chisa InoueDepartment of Diabetes and Endocrinology, Mie University Faculty and Graduate School of Medicine, Tsu, Mie, Japan.ORCID 0000-0002-7022-9156
Takehiro TakagiIwasaki Hospital, Tsu, Mie, Japan.
Hiroyuki MukaiyamaTanisake Corporation, Gifu, Japan.ORCID 0000-0003-1842-1965
Norio TakagiTanisake Corporation, Gifu, Japan.
Katsumi ShimizuTanisake Corporation, Gifu, Japan.
Yutaka YanoDepartment of Diabetes and Endocrinology, Mie University Faculty and Graduate School of Medicine, Tsu, Mie, Japan.
Esteban C GabazzaDepartment of Immunology, Mie University Faculty and Graduate School of Medicine, Tsu, Mie, Japan.ORCID 0000-0001-5748-1499
Mie University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionDiabetes mellitus is a serious threat to public health worldwide. It causes a substantial economic burden, mental and physical disabilities, poor quality of life, and high mortality. Limonite is formed when iron-rich materials from the underground emerge and oxidized on the ground surface. It is currently used to purify contaminated water, absorption of irritant gases, and improve livestock breeding. Limonite can change the composition of environmental microbial communities. In the present study, we evaluated whether limonite can ameliorate glucose metabolism abnormalities by remodeling the gut microbiome.

methodsThe investigation was performed using mouse models of streptozotocin-induced diabetes mellitus and high-calorie diet-induced metabolic syndrome.

resultsOral limonite supplement was associated with significant body weight recovery, reduced glycemia with improved insulin secretion, increased number of regulatory T cells, and abundant beneficial gut microbial populations in mice with diabetes mellitus compared to control. Similarly, mice with obesity fed with limonite supplements had significantly reduced body weight, insulin resistance, steatohepatitis, and systemic inflammatory response with significant gut microbiome remodeling.

conclusionThis study demonstrates that limonite supplement ameliorates abnormal glucose metabolism in diabetes mellitus and obesity. Gut microbiome remodeling, inhibition of inflammatory cytokines, and the host immune response regulation may explain the limonite's beneficial activity under pathological conditions in vivo.

Indexed as

diabetesgut microbiomeinsulin resistancelimonitemetabolic syndromestreptozotocin

Identifiers

PMID34276223
PMCPMC8277451
OpenAlexW3181437526

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.